ag-1296 has been researched along with palbociclib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Becknell, B; Benson, DM; Briesewitz, R; Caligiuri, MA; Ferketich, AK; Freud, AG; Perrotti, D; Trotta, R; Wei, M; Yu, J | 1 |
1 other study(ies) available for ag-1296 and palbociclib
Article | Year |
---|---|
Stem cell factor and interleukin-2/15 combine to enhance MAPK-mediated proliferation of human natural killer cells.
Topics: Cell Division; Cells, Cultured; Culture Media, Serum-Free; Cyclin-Dependent Kinase 4; Drug Synergism; Humans; Interleukin-15; Interleukin-2; Killer Cells, Natural; MAP Kinase Signaling System; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyridines; Recombinant Proteins; Stem Cell Factor; Tyrphostins; Up-Regulation | 2009 |